Metformin upregulates progesterone receptors (making endometrium more sensitive to progesterone therapy), downregulates circulating insulin (insulin acts as growth factor for endometrial cancer cells), and inhibits proliferation and migration of endometrial cancer cells. The gene discussed is PGR; the disease is endometrial cancer.